vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and MEDALLION FINANCIAL CORP (MFIN). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $70.6M, roughly 1.2× MEDALLION FINANCIAL CORP). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 17.3%, a 5.5% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 25.4%). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 15.0%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
Mahindra & Mahindra Financial Services Limited (MMFSL) is an Indian rural non-banking financial company headquartered in Mumbai. It is amongst the top tractor financers in India, with 1000+ offices across the country.
FDMT vs MFIN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $70.6M |
| Net Profit | $19.4M | $12.2M |
| Gross Margin | — | — |
| Operating Margin | 17.3% | 29.3% |
| Net Margin | 22.8% | 17.3% |
| Revenue YoY | 8508900.0% | 25.4% |
| Net Profit YoY | 139.1% | 20.3% |
| EPS (diluted) | $0.43 | $0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $70.6M | ||
| Q3 25 | $90.0K | $58.7M | ||
| Q2 25 | $15.0K | $62.6M | ||
| Q1 25 | $14.0K | $63.0M | ||
| Q4 24 | $1.0K | $56.3M | ||
| Q3 24 | $3.0K | $53.3M | ||
| Q2 24 | $5.0K | $51.0M | ||
| Q1 24 | $28.0K | $53.3M |
| Q4 25 | $19.4M | $12.2M | ||
| Q3 25 | $-56.9M | $7.8M | ||
| Q2 25 | $-54.7M | $11.1M | ||
| Q1 25 | $-48.0M | $12.0M | ||
| Q4 24 | — | $10.1M | ||
| Q3 24 | $-43.8M | $8.6M | ||
| Q2 24 | $-35.0M | $7.1M | ||
| Q1 24 | $-32.4M | $10.0M |
| Q4 25 | 17.3% | 29.3% | ||
| Q3 25 | -67983.3% | 33.2% | ||
| Q2 25 | -396373.3% | 31.1% | ||
| Q1 25 | -383007.1% | 32.1% | ||
| Q4 24 | — | 32.8% | ||
| Q3 24 | -1704400.0% | 26.6% | ||
| Q2 24 | -849120.0% | 24.3% | ||
| Q1 24 | -136200.0% | 33.6% |
| Q4 25 | 22.8% | 17.3% | ||
| Q3 25 | -63195.6% | 13.2% | ||
| Q2 25 | -364386.7% | 17.7% | ||
| Q1 25 | -342657.1% | 19.1% | ||
| Q4 24 | — | 18.0% | ||
| Q3 24 | -1461433.3% | 16.1% | ||
| Q2 24 | -699060.0% | 13.9% | ||
| Q1 24 | -115717.9% | 18.8% |
| Q4 25 | $0.43 | $0.50 | ||
| Q3 25 | $-1.01 | $0.32 | ||
| Q2 25 | $-0.98 | $0.46 | ||
| Q1 25 | $-0.86 | $0.50 | ||
| Q4 24 | — | $0.43 | ||
| Q3 24 | $-0.79 | $0.37 | ||
| Q2 24 | $-0.63 | $0.30 | ||
| Q1 24 | $-0.66 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $136.3M |
| Total DebtLower is stronger | — | $216.0M |
| Stockholders' EquityBook value | $505.7M | $408.6M |
| Total Assets | $566.7M | $3.0B |
| Debt / EquityLower = less leverage | — | 0.53× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $136.3M | ||
| Q3 25 | $305.1M | $72.5M | ||
| Q2 25 | $293.2M | $110.4M | ||
| Q1 25 | $321.4M | $131.5M | ||
| Q4 24 | $424.9M | $98.2M | ||
| Q3 24 | $501.9M | $120.6M | ||
| Q2 24 | $541.9M | $87.7M | ||
| Q1 24 | $525.9M | $54.8M |
| Q4 25 | — | $216.0M | ||
| Q3 25 | — | $215.7M | ||
| Q2 25 | — | $199.9M | ||
| Q1 25 | — | $199.7M | ||
| Q4 24 | — | $232.2M | ||
| Q3 24 | — | $232.0M | ||
| Q2 24 | — | $230.8M | ||
| Q1 24 | — | $225.6M |
| Q4 25 | $505.7M | $408.6M | ||
| Q3 25 | $369.0M | $397.4M | ||
| Q2 25 | $420.9M | $389.9M | ||
| Q1 25 | $469.7M | $380.2M | ||
| Q4 24 | $510.6M | $370.2M | ||
| Q3 24 | $552.9M | $362.4M | ||
| Q2 24 | $588.3M | $354.0M | ||
| Q1 24 | $600.6M | $349.0M |
| Q4 25 | $566.7M | $3.0B | ||
| Q3 25 | $424.0M | $2.9B | ||
| Q2 25 | $473.6M | $2.9B | ||
| Q1 25 | $515.7M | $2.8B | ||
| Q4 24 | $560.4M | $2.9B | ||
| Q3 24 | $604.0M | $2.9B | ||
| Q2 24 | $620.1M | $2.8B | ||
| Q1 24 | $629.9M | $2.6B |
| Q4 25 | — | 0.53× | ||
| Q3 25 | — | 0.54× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 0.53× | ||
| Q4 24 | — | 0.63× | ||
| Q3 24 | — | 0.64× | ||
| Q2 24 | — | 0.65× | ||
| Q1 24 | — | 0.65× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $126.3M |
| Free Cash FlowOCF − Capex | $28.5M | — |
| FCF MarginFCF / Revenue | 33.5% | — |
| Capex IntensityCapex / Revenue | 0.1% | — |
| Cash ConversionOCF / Net Profit | 1.47× | 10.35× |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $126.3M | ||
| Q3 25 | $-46.5M | $67.0M | ||
| Q2 25 | $-43.4M | $-10.7M | ||
| Q1 25 | $-47.8M | $36.3M | ||
| Q4 24 | $-134.6M | $108.7M | ||
| Q3 24 | $-29.4M | $24.6M | ||
| Q2 24 | $-30.2M | $27.6M | ||
| Q1 24 | $-29.1M | $32.3M |
| Q4 25 | $28.5M | — | ||
| Q3 25 | $-46.6M | — | ||
| Q2 25 | $-43.4M | — | ||
| Q1 25 | $-48.4M | — | ||
| Q4 24 | $-138.4M | — | ||
| Q3 24 | $-31.2M | — | ||
| Q2 24 | $-30.6M | — | ||
| Q1 24 | $-29.8M | — |
| Q4 25 | 33.5% | — | ||
| Q3 25 | -51765.6% | — | ||
| Q2 25 | -289620.0% | — | ||
| Q1 25 | -345635.7% | — | ||
| Q4 24 | -13837100.0% | — | ||
| Q3 24 | -1038966.7% | — | ||
| Q2 24 | -611840.0% | — | ||
| Q1 24 | -106421.4% | — |
| Q4 25 | 0.1% | — | ||
| Q3 25 | 101.1% | — | ||
| Q2 25 | 440.0% | — | ||
| Q1 25 | 4507.1% | — | ||
| Q4 24 | 378600.0% | — | ||
| Q3 24 | 59266.7% | — | ||
| Q2 24 | 6980.0% | — | ||
| Q1 24 | 2535.7% | — |
| Q4 25 | 1.47× | 10.35× | ||
| Q3 25 | — | 8.63× | ||
| Q2 25 | — | -0.97× | ||
| Q1 25 | — | 3.02× | ||
| Q4 24 | — | 10.72× | ||
| Q3 24 | — | 2.86× | ||
| Q2 24 | — | 3.89× | ||
| Q1 24 | — | 3.22× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
